Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy

Gut

Volumn 67, Issue 3, 2018, Pages 534-571

  Tang, Ruqi ^a   Wei, Yiran ^a   Li, Yanmei ^a   Chen, Weihua ^a   Chen, Haoyan ^a   Wang, Qixia ^a   Yang, Fan ^a   Miao, Qi ^a   Xiao, Xiao ^a   Zhang, Haiyan ^a   Lian, Min ^a   Jiang, Xiang ^a   Zhang, Jun ^a   Cao, Qin ^b   Fan, Zhuping ^b   Wu, Maoying ^b   Qiu, Dekai ^a   Fang, Jing Yuan ^a   Ansari, Aftab ^c   Gershwin, M Eric ^d   Ma, Xiong ^a   more..

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Intestinal Bacteria; Primary Biliary Cirrhosis

Indexed keywords

BIOLOGICAL MARKER; RNA 16S; URSODEOXYCHOLIC ACID; ANTIBODY; CHOLAGOGUE; NUCLEOPORIN; NUP210 PROTEIN, HUMAN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CELL INVASION; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DYSBIOSIS; ENTEROBACTERIACEAE; EPITHELIUM CELL; FAECALIBACTERIUM; FECES ANALYSIS; FEMALE; GENE SEQUENCE; HUMAN; INTESTINE FLORA; MAJOR CLINICAL STUDY; MALE; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; NONHUMAN; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; BACTERIUM; BLOOD; CASE CONTROL STUDY; CHOLANGITIS; COMPLICATION; DRUG EFFECTS; FECES; IMMUNOLOGY; MICROBIOLOGY; MIDDLE AGED; YOUNG ADULT;

ADULT; AGED; ANTIBODIES; BACTERIA; BIOMARKERS; CASE-CONTROL STUDIES; CHOLAGOGUES AND CHOLERETICS; CHOLANGITIS; CROSS-SECTIONAL STUDIES; DYSBIOSIS; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; MALE; MIDDLE AGED; NUCLEAR PORE COMPLEX PROTEINS; PROSPECTIVE STUDIES; URSODEOXYCHOLIC ACID; YOUNG ADULT;

EID: 85042885903     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2016-313332     Document Type: Article

References (44)

1. Griffiths L, Dyson JK, Jones DE. The new epidemiology of primary biliary cirrhosis. Semin Liver Dis 2014;34:318-28.
2. James OF, Bhopal R, Howel D, et al. Primary biliary cirrhosis once rare, now common in the United Kingdom Hepatology 1999;30:390-4.
3. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med 2005;353:1261-73.
4. Carey EJ, Ali AH, Lindor KD. Primary biliary cirrhosis. Lancet 2015;386:1565-75.
5. Juran BD, Lazaridis KN. Environmental factors in primary biliary cirrhosis. Semin Liver Dis 2014;34:265-72.
6. Seldin MF. The genetics of human autoimmune disease: A perspective on progress in the field and future directions. J Autoimmun 2015;64:1-12.
7. Wang YH, Yang W, Yang JB, et al. Systems biologic analysis of T regulatory cells genetic pathways in murine primary biliary cirrhosis. J Autoimmun 2015;59:26-37.
8. Webb GJ, Hirschfield GM. Using GWAS to identify genetic predisposition in hepatic autoimmunity. J Autoimmun 2016;66:25-39.
9. Webb GJ, Siminovitch KA, Hirschfield GM. The immunogenetics of primary biliary cirrhosis: A comprehensive review. J Autoimmun 2015;64:42-52.
10. Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nat Rev Immunol 2016;16:341-52.
11. Marchesi JR, Adams DH, Fava F, et al. The gut microbiota and host health: A new clinical frontier. Gut 2016;65:330-9.
12. Li J, Jia H, Cai X, et al. An integrated catalog of reference genes in the human gut microbiome. Nat Biotechnol 2014;32:834-41.
13. Kummen M, Holm K, Anmarkrud JA, et al. The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls. Gut 2016. doi:10.1136/gutjnl-2015-310500. [Epub ahead of print 17 Feb 2016]
14. Sabino J, Vieira-Silva S, Machiels K, et al. Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD. Gut 2016;65:1681-9.
15. Leung C, Rivera L, Furness JB, et al. The role of the gut microbiota in NAFLD. Nat Rev Gastroenterol Hepatol 2016;13:412-25.
16. Qin N, Yang F, Li A, et al. Alterations of the human gut microbiome in liver cirrhosis. Nature 2014;513:59-64.
17. Ma HD, Wang YH, Chang C, et al. The intestinal microbiota and microenvironment in liver. Autoimmun Rev 2015;14:183-91.
18. Henao-Mejia J, Elinav E, Thaiss CA, et al. Role of the intestinal microbiome in liver disease. J Autoimmun 2013;46:66-73.
19. Wahlström A, Sayin SI, Marschall HU, et al. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab 2016;24:41-50.
20. Ridlon JM, Kang DJ, Hylemon PB, et al. Bile acids and the gut microbiome. Curr Opin Gastroenterol 2014;30:332-8.
21. Lv LX, Fang DQ, Shi D, et al. Alterations and correlations of the gut microbiome, metabolism and immunity in patients with primary biliary cirrhosis. Environ Microbiol 2016;18:2272-86.
22. Lindor KD, Gershwin ME, Poupon R, et al. Primary biliary cirrhosis. Hepatology 2009;50:291-308.
23. Chazouillères O, Wendum D, Serfaty L, et al. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: Clinical features and response to therapy. Hepatology 1998;28:296-301.
24. Corpechot C, Chazouillères O, Poupon R. Early primary biliary cirrhosis: Biochemical response to treatment and prediction of long-term outcome. J Hepatol 2011;55:1361-7.
25. Kuczynski J, Stombaugh J, Walters WA, et al. Using QIIME to analyze 16S rRNA gene sequences from microbial communities. Curr Protoc Microbiol 2012;Chapter 1: Unit 1E.5.
26. Navas-Molina JA, Peralta-Sánchez JM, González A, et al. Advancing our understanding of the human microbiome using QIIME. Meth Enzymol 2013; 531:371-444.
27. Langille MG, Zaneveld J, Caporaso JG, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol 2013;31:814-21.
28. ter Borg PC, Schalm SW, Hansen BE, et al. Prognosis of ursodeoxycholic Acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients. Am J Gastroenterol 2006;101:2044-50.
29. Nakamura M, Kondo H, Mori T, et al. Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology 2007;45:118-27.
30. Tang R, Chen H, Miao Q, et al. The cumulative effects of known susceptibility variants to predict primary biliary cirrhosis risk. Genes Immun 2015;16:193-8.
31. Stemerowicz R, Hopf U, Möller B, et al. Are antimitochondrial antibodies in primary biliary cirrhosis induced by R(rough)-mutants of enterobacteriaceae Lancet 1988;2:1166-70.
32. Rashid T, Ebringer A. Autoimmunity in rheumatic diseases is induced by microbial infections via crossreactivity or molecular mimicry. Autoimmune Dis 2012;2012:539282.
33. Paczosa MK, Mecsas J. Klebsiella pneumoniae: Going on the offense with a strong defense. Microbiol Mol Biol Rev 2016;80:629-61.
34. Smyk DS, Bogdanos DP, Kriese S, et al. Urinary tract infection as a risk factor for autoimmune liver disease: From bench to bedside. Clin Res Hepatol Gastroenterol 2012;36:110-21.
35. De Cruz P, Kang S, Wagner J, et al. Association between specific mucosa-associated microbiota in Crohn's disease at the time of resection and subsequent disease recurrence: A pilot study. J Gastroenterol Hepatol 2015;30:268-78.
36. Rovery C, Etienne A, Foucault C, et al. Veillonella montpellierensis endocarditis. Emerg Infect Dis 2005;11:1112-14.
37. Coburn B, Wang PW, Diaz Caballero J, et al. Lung microbiota across age and disease stage in cystic fibrosis. Sci Rep 2015;5:10241.
38. Yurkovetskiy L, Burrows M, Khan AA, et al. Gender bias in autoimmunity is influenced by microbiota. Immunity 2013;39:400-12.
39. Markle JG, Frank DN, Adeli K, et al. Microbiome manipulation modifies sex-specific risk for autoimmunity. Gut Microbes 2014;5:485-93.
40. Ribet D, Cossart P. How bacterial pathogens colonize their hosts and invade deeper tissues. Microbes Infect 2015;17:173-83.
41. Tuomisto S, Pessi T, Collin P, et al. Changes in gut bacterial populations and their translocation into liver and ascites in alcoholic liver cirrhotics. BMC Gastroenterol 2014;14:40.
42. Wiest R, Lawson M, Geuking M. Pathological bacterial translocation in liver cirrhosis. J Hepatol 2014;60:197-209.
43. Parthasarathy G, Chen J, Chen X, et al. Relationship Between microbiota of the colonic mucosa vs feces and symptoms, colonic transit, and methane production in female patients with chronic constipation. Gastroenterology 2016;150:367-79.e1.
44. Smith B, Li N, Andersen AS, et al. Optimising bacterial DNA extraction from faecal samples: Comparison of three methods. Open Microbiol J 2011;5:14-17.